You are here:

levetiracetam 500mg/5ml concentrate for infusion (Keppra)

Advice

Following an abbreviated submission

levetiracetam 500mg/5ml concentrate for infusion (Keppra) is accepted for use in NHS Scotland as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. It is an alternative when oral administration is temporarily not feasible in patients for whom levetiracetam is an appropriate anticonvulsant.

Intravenous infusion is associated with a greater cost per dose.

Drug Details

Drug Name: levetiracetam 500mg/5ml concentrate for infusion (Keppra)
SMC Drug ID: 311/06
Manufacturer: UCB Pharma Ltd
Indication: Epilepsy
BNF Category:
Sub Category: 4.8 Antiepileptic drugs
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 9 October 2006

Back